Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European (EU) Multi-Center Registry to Assess Outcomes in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery: Treatment of Vascular Conduits With DuraGraft®, a Novel Endothelial Damage Inhibitor [VASC]

NCT02922088 is registered in ClinicalTrials.gov with Somahlution LLC as lead sponsor.

NCT NCT02922088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02922088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European (EU) Multi-Center Registry to Assess Outcomes in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery: Treatment of Vascular Conduits With DuraGraft®, a Novel Endothelial Damage Inhibitor [VASC]
Lead sponsor
Somahlution LLC
Phase
Observational
Overall status
Unknown status
Start date
December 9, 2016
Completion date
December 31, 2024
Enrollment
2,964 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, coronary artery disease